Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
BACKGROUND AND PURPOSE: Stroke risk increases with age in patients who have nonvalvular atrial fibrillation. It is uncertain whether the efficacy of stroke prevention therapies in atrial fibrillation changes as patients age. The objective of this study was to determine the effect of age on the relat...
Main Authors: | van Walraven, C, Hart, R, Connolly, S, Austin, P, Mant, J, Hobbs, F, Koudstaal, P, Petersen, P, Perez-Gomez, F, Knottnerus, J, Boode, B, Ezekowitz, MD, Singer, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Stroke prevention in atrial fibrillation
by: Hobbs, F
Published: (2003) -
Challenges of stroke prevention in patients with atrial fibrillation in clinical practice.
by: Hobbs, F, et al.
Published: (2011) -
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
by: Mant, J, et al.
Published: (2007) -
Should we screen for atrial fibrillation?
by: Lown, M, et al.
Published: (2017) -
Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
by: Mavaddat, N, et al.
Published: (2014)